Retatrutide
Triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors in metabolic research.
$108.00
In stock — ships in 1–2 business days
Independent HPLC and mass-spec analysis is performed on every batch. Current COAs are published here and available on request.
For laboratory and research use only. Not for human consumption. These products are not intended to diagnose, treat, cure, or prevent any disease.
Triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors in metabolic research.
Retatrutide is supplied as a lyophilized powder for laboratory research. DexaLabs does not publish dosing, administration or protocol guidance, and nothing on this page should be read as such.
Browse published literature on Retatrutide (PubMed) →
For laboratory and research use only. Not for human consumption. These products are not intended to diagnose, treat, cure, or prevent any disease.